Coverage dated December 11, 2021 to December 13, 2021
Pfizer vaccine protects 70% against hospitalization from omicron, study finds
Headline from Foxla, on the newest of 2 developments
A large South African analysis found Pfizer’s COVID-19 vaccine offered just 33% protection against infection by the omicron variant, but 70% protection against hospitalization.
Foxla's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Protection from Omicron jumps 100-fold with Pfizer booster shot: Israeli researchers
Headline from Newsweek ·
Newest
Pfizer vaccine protects 70% against hospitalization from omicron, study finds
Compared to a two-dose track with the Pfizer vaccine, researchers found that getting a third booster reduces the chance of infection from Omicron significantly.
An Israeli study appears to support findings from Pfizer and BioNTech that three doses of their vaccine, including a booster as well as an initial two-shot regimen,
A large South African analysis found Pfizer’s COVID-19 vaccine offered just 33% protection against infection by the omicron variant, but 70% protection against hospitalization.
While the findings are preliminary and have not been peer-reviewed, they line up with other early data that indicated omicron seems to be more easily transmitted.
The omicron variant appears to cause less severe disease than previous versions of the coronavirus, and the Pfizer vaccine seems to offer less defense against infection from it but still good protection from hospitalization, according to an analysis of data from South Africa, where the new variant i…
The omicron Covid-19 variant appeared to cause less severe illness in South Africa but was more resistant to the Pfizer vaccine, according to the first major real-world study
Preliminary analysis of the latest real-world data from South Africa shows that while two shots of the vaccine alone may not stop an infection, it will help avoid serious illness.
JOHANNESBURG (AP) — A two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron variant of the coronavirus, but 70% protection against hospitalization, according to a large-scale analysis
A new South African study finds that the two-dose Pfizer-BioNTech COVID-19 vaccine is 70 percent effective at preventing hospitalizations due to the omicron variant.
Data from 78,000 South Africans with COVID show the Pfizer vaccine is far less effective in preventing infection by the omicron variant. But there is still significant protection from severe illness.
The first large-scale analysis of vaccine effectiveness in South Africa appears to support early indications that omicron is more easily transmissible.
TUESDAY, Dec. 14, 2021 (HealthDay News) -- Compared to previous coronavirus variants, Omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South
New variant appears to cause less severe illness than previous versions of coronavirus, but seems to be more easily transmitted and is better at evading vaccines
As the omicron variant continues to spread around the globe, new data from South Africa confirms the highly transmissible variant may cause less severe disease but is better at evading today’s vaccines.
Scientists in South Africa have found that the effectiveness of the Pfizer vaccine to prevent SARS-CoV-2 infections has dropped to about 30% for the omicron variant.
A two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron variant of the coronavirus, but 70% protection against hospitalization, according to an analysis done in South Africa and released Tuesday.
A large-scale analysis in South Africa says that two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron coronavirus variant but 70% protection against hospitalization
Showing the first 25 of 29 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Pfizer vaccine protects 70% against hospitalization from omicron, study finds | Since Then
